ERVW-1 and adult T-cell leukemia/lymphoma: Our findings in this study support the hypothesis of the potential use of HERV-K Env and HERV-H Env antibodies as biomarkers of ATLL disease progression; it may be helpful to more thoroughly evaluate the diagnostic and prognostic values of HERV antibodies.